Article 27 Jan 2017 Biosimilars: Supreme Court Grants Certiorari In Amgen v. Sandoz United States Litigation
Article 29 Dec 2016 Biosimilars: Solicitor General Recommends Granting Certiorari In Amgen v. Sandoz United States IP
Article 19 Aug 2016 Will The Supreme Court Review Whether FDA-Mandated Bioequivalence Testing To Maintain Approval Falls Within The § 271(e)(1) Safe Harbor? United States Healthcare
Article 25 Jul 2016 Federal Circuit: A Biosimilar Applicant Must Provide Notice Of Intent To Market A Biosimilar Product, No Exceptions United States Healthcare
Article 20 Jul 2016 Litigation Alert: No Exception To Statutory Requirement That A Biosimilar Applicant Provide Notice Of Intent To Market Its Product United States IP
Article 30 Jun 2016 Biosimilars: Supreme Court Calls For Solicitor General's Views In Amgen V. Sandoz United States Healthcare